# Study on the Effect of a Beta Blocker on Increased Sensitivity to Pain in Humans Caused by Opioids

> **NCT01222091** · PHASE2 · COMPLETED · sponsor: **Stanford University** · enrollment: 10 (actual)

## Conditions studied

- Hyperalgesia

## Interventions

- **DRUG:** Propranolol
- **DRUG:** Placebo to Match Propranolol
- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT01222091
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2011-05
- **Final completion:** 2011-06
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01222091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01222091, "Study on the Effect of a Beta Blocker on Increased Sensitivity to Pain in Humans Caused by Opioids". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01222091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*